There was an interesting trend in intrahepatic cholangiocarcinoma tumors whereby patients with upregulation of CEBPA RNA 24 h after drug administration appeared more likely to have a response or disease stabilization, and we saw higher disease control rates in this subgroup (disease control rate by RECIST = 80%). Here, CEBPA is linked to intrahepatic cholangiocarcinoma.